Long-term changes in cardiac remodelling in prevalent kidney graft recipients

被引:2
|
作者
Panisset, Valentin [1 ]
Girerd, Nicolas [2 ,3 ,4 ,5 ]
Bozec, Erwan [2 ,3 ,4 ,5 ]
Lamiral, Zohra [2 ,3 ,4 ,5 ]
d'Herve, Quentin [1 ]
Frimat, Luc [1 ]
Huttin, Olivier [6 ]
Girerd, Sophie [1 ,2 ,3 ,4 ,5 ,7 ,8 ]
机构
[1] Univ Hosp Nancy, Nephrol Dept, Vandoeuvre Les Nancy, France
[2] Univ Lorraine, Ctr Invest Clin 1433, Inserm, Vandoeuvre Les Nancy, France
[3] Inserm, U1116, Vandoeuvre Les Nancy, France
[4] CHRU Nancy, Vandoeuvre Les Nancy, France
[5] F CRIN INI CRCT, Vandoeuvre Les Nancy, France
[6] Univ Hosp Nancy, Cardiol Dept, Vandoeuvre Les Nancy, France
[7] CHRU Nancy, Ctr Invest Clin 1433, INSERM,U1116, Nancy, France
[8] 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
关键词
Kidney transplantation; Kidney graft recipients; Echocardiography; Cardiac remodelling; Heart failure; LEFT-VENTRICULAR HYPERTROPHY; RENAL-TRANSPLANT RECIPIENTS; LEFT ATRIAL DIAMETER; SURVIVAL; ADULTS; MANAGEMENT; EVEROLIMUS; PROGNOSIS; OUTCOMES; DISEASE;
D O I
10.1016/j.ijcard.2024.131852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Approximately 15% of kidney transplant (KT) recipients develop de novo heart failure after KT. There are scarce data reporting the long-term changes in cardiac structure and function among KT recipients. Despite the improvement in renal function, transplant-related complications as well as immunosuppressive therapy could have an impact on cardiac remodelling during follow-up. We aimed to describe the long-term changes in echocardiographic parameters in prevalent KT recipients and identify the clinical and laboratory factors associated with these changes. Methods: A centralised blinded review of two echocardiographic examinations after KT (on average after 17 and 39 months post-KT respectively) was performed among 80 patients (age 50.4 +/- 16.2, diabetes 13.8% pre-KT), followed by linear regression to identify clinico-biological factors related to echocardiographic changes. Results: Left atrial volume index (LAVI) increased significantly (34.2 +/- 10.8 mL/m(2) vs. 37.6 +/- 15.0 mL/m(2), annualised delta 3.1 +/- 11.4 mL/m(2)/year; p = 0.034) while left ventricular ejection fraction (LVEF) decreased (62.1 +/- 9.0% vs. 59.7 +/- 9.9%, annualised delta -2.7 +/- 13.6%/year; p = 0.04). Male sex (beta = 8.112 +/- 2.747; p < 0.01), pre-KT hypertension (beta = 9.725 +/- 4.156; p < 0.05), graft from expanded criteria donor (beta = 3.791 +/- 3.587; p < 0.05), and induction by anti-thymocyte globulin (beta = 7.920 +/- 2.974; p = 0.01) were associated with an increase in LAVI during follow-up. Higher haemoglobin (>12.9 g/dL) at the time of the first echocardiography (beta = 6.029 +/- 2.967; p < 0.05) and ACEi/ARB therapy (beta = 8.306 +/- 3.161; p < 0.05) were associated with an increase in LVEF during follow-up. Conclusion: This study confirms the existence of long-term cardiac remodelling after KT despite dialysis cessation, characterised by an increase in LAVI and a decrease in LVEF. A better management of anaemia and using ACEi/ARB therapy may prevent such remodelling.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients
    Sotomayor, Camilo G.
    Gomes-Neto, Antonio W.
    van Londen, Marco
    Gans, Rijk O. B.
    Nolte, Ilja M.
    Berger, Stefan P.
    Navis, Gerjan J.
    Rodrigo, Ramon
    Leuvenink, Henri G. D.
    Schalkwijk, Casper G.
    Bakker, Stephan J. L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1512 - 1520
  • [22] The Relationship Between Kidney Function and Long-term Graft Survival After Kidney Transplant
    Kasiske, Bertram L.
    Israni, Ajay K.
    Snyder, Jon J.
    Skeans, Melissa A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (03) : 466 - 475
  • [23] Small donors for small recipients - excellent growth and long-term function of single kidney grafts
    Cetiner, Metin
    Paul, Andreas
    Treckmann, Juergen W.
    Dittmann, Susanne
    Buescher, Rainer
    Hoyer, Peter F.
    Buescher, Anja K.
    TRANSPLANT INTERNATIONAL, 2021, 34 (12) : 2735 - 2745
  • [24] The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial
    Tsujita, Makoto
    Kosugi, Tomoki
    Goto, Norihiko
    Futamura, Kenta
    Nishihira, Morikuni
    Okada, Manabu
    Hiramitsu, Takahisa
    Narumi, Shunji
    Uchida, Kazuharu
    Takeda, Asami
    Morozumi, Kunio
    Maruyama, Shoichi
    Watarai, Yoshihiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1409 - 1416
  • [25] Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients
    Jonathan P. Law
    Richard Borrows
    David McNulty
    Adnan Sharif
    Charles J. Ferro
    BMC Nephrology, 22
  • [26] Orthostatic Hypotension and Cardiac Changes After Long-Term Follow-Up
    Magnusson, Martin
    Holm, Hannes
    Bachus, Erasmus
    Nilsson, Peter
    Leosdottir, Margret
    Melander, Olle
    Jujic, Amra
    Fedorowski, Artur
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (07) : 847 - 852
  • [27] Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy
    Foley, Paul W. X.
    Chalil, Shajil
    Khadjooi, Kayvan
    Irwin, Nick
    Smith, Russell E. A.
    Leyva, Francisco
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (01) : 43 - 51
  • [28] Long-term tacrolimus versus long-term ciclosporin in renal transplant recipients with poor graft function
    Pattison, James
    Sacks, Steven
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (11): : 598 - 599
  • [29] Long-term Graft Survival and Graft Function Following Pregnancy in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
    van Buren, Marleen C.
    Schellekens, Anouk
    Groenhof, T. Katrien J.
    van Reekum, Franka
    van de Wetering, Jacqueline
    Paauw, Nina D.
    Lely, A. Titia
    TRANSPLANTATION, 2020, 104 (08) : 1675 - 1685
  • [30] Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin
    Cortazar, F.
    Molnar, M. Z.
    Isakova, T.
    Czira, M. E.
    Kovesdy, C. P.
    Roth, D.
    Mucsi, I.
    Wolf, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (02) : 379 - 387